Efficacy and safety of ixekizumab versus adalimumab in patients with PsA Presented ByDr Roy Fleischmann, University of Texas Southwestern Medical Center, Dallas, USA ConferenceEULAR 2019 TypePeer-reviewed article 4 September 2019 11:20